{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:45:17Z","timestamp":1792143917196,"version":"4.4.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Familial hypocholesterolemia, namely abetalipoproteinemia, hypobetalipoproteinemia and chylomicron retention disease (CRD), are rare genetic diseases that cause malnutrition, failure to thrive, growth failure and vitamin E deficiency, as well as other complications. Recently, the gene implicated in CRD was identified. The diagnosis is often delayed because symptoms are nonspecific. Treatment and follow-up remain poorly defined.<\/jats:p><jats:p>The aim of this paper is to provide guidelines for the diagnosis, treatment and follow-up of children with CRD based on a literature overview and two pediatric centers 'experience.<\/jats:p><jats:p>The diagnosis is based on a history of chronic diarrhea with fat malabsorption and abnormal lipid profile. Upper endoscopy and histology reveal fat-laden enterocytes whereas vitamin E deficiency is invariably present. Creatine kinase (CK) is usually elevated and hepatic steatosis is common. Genotyping identifies the<jats:italic>Sar1b<\/jats:italic>gene mutation.<\/jats:p><jats:p>Treatment should be aimed at preventing potential complications. Vomiting, diarrhea and abdominal distension improve on a low-long chain fat diet. Failure to thrive is one of the most common initial clinical findings. Neurological and ophthalmologic complications in CRD are less severe than in other types of familial hypocholesterolemia. However, the vitamin E deficiency status plays a pivotal role in preventing neurological complications. Essential fatty acid (EFA) deficiency is especially severe early in life. Recently, increased CK levels and cardiomyopathy have been described in addition to muscular manifestations. Poor mineralization and delayed bone maturation do occur. A moderate degree of macrovesicular steatosis is common, but no cases of steatohepatitis cirrhosis.<\/jats:p><jats:p>Besides a low-long chain fat diet made up uniquely of polyunsaturated fatty acids, treatment includes fat-soluble vitamin supplements and large amounts of vitamin E. Despite fat malabsorption and the absence of postprandial chylomicrons, the oral route can prevent neurological complications even though serum levels of vitamin E remain chronically low. Dietary counseling is needed not only to monitor fat intake and improve symptoms, but also to maintain sufficient caloric and EFA intake.<\/jats:p><jats:p>Despite a better understanding of the pathogenesis of CRD, the diagnosis and management of the disease remain a challenge for clinicians. The clinical guidelines proposed will helpfully lead to an earlier diagnosis and the prevention of complications.<\/jats:p>","DOI":"10.1186\/1750-1172-5-24","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T06:17:05Z","timestamp":1285741025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers"],"prefix":"10.1186","volume":"5","author":[{"given":"Noel","family":"Peretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Sassolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude C","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Deslandres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Charcosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Castagnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Pugnet-Chardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Labarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Bouthillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lachaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,29]]},"reference":[{"key":"187_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-physiol-021909-135801","volume":"72","author":"CM Mansbach","year":"2010","unstructured":"Mansbach CM, Siddiqi SA: The biogenesis of chylomicrons. Annu Rev Physiol. 2010, 72: 315-333. 10.1146\/annurev-physiol-021909-135801.","journal-title":"Annu Rev Physiol"},{"key":"187_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosissup.2010.03.003","volume":"11","author":"T Kindel","year":"2010","unstructured":"Kindel T, Lee DM, Tso P: The mechanism of the formation and secretion of chylomicrons. Atheroscler Suppl. 2010, 11: 11-16. 10.1016\/j.atherosclerosissup.2010.03.003.","journal-title":"Atheroscler Suppl"},{"key":"187_CR3","doi-asserted-by":"crossref","first-page":"21951","DOI":"10.1016\/S0021-9258(17)31740-4","volume":"269","author":"JM Leiper","year":"1994","unstructured":"Leiper JM, Bayliss JD, Pease RJ, Brett DJ, Scott J, Shoulders CC: Microsomal triglyceride transfer protein, the abetalipoproteinemia gene product, mediates the secretion of apolipoprotein B-containing lipoproteins from heterologous cells. J Biol Chem. 1994, 269: 21951-21954.","journal-title":"J Biol Chem"},{"key":"187_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2009.01.037","volume":"206","author":"D Noto","year":"2009","unstructured":"Noto D, Cefalu AB, Cannizzaro A, Mina M, Fayer F, Valenti V, Barbagallo CM, Tuttolomondo A, Pinto A, Sciume C, Licata G, Averna M: Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. Atherosclerosis. 2009, 206: 193-198. 10.1016\/j.atherosclerosis.2009.01.037.","journal-title":"Atherosclerosis"},{"key":"187_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1126\/science.1439810","volume":"258","author":"JR Wetterau","year":"1992","unstructured":"Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, Schmitz J, Gay G, Rader DJ, Gregg RE: Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 1992, 258: 999-1001. 10.1126\/science.1439810.","journal-title":"Science"},{"key":"187_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/365065a0","volume":"365","author":"D Sharp","year":"1993","unstructured":"Sharp D, Blinderman L, Combs KA, Kienzle B, Ricci B, Wager-Smith K, Gil CM, Turck CW, Bouma ME, Rader DJ: Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature. 1993, 365: 65-69. 10.1038\/365065a0.","journal-title":"Nature"},{"key":"187_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00041433-200404000-00012","volume":"15","author":"CC Shoulders","year":"2004","unstructured":"Shoulders CC, Stephens DJ, Jones B: The intracellular transport of chylomicrons requires the small GTPase, Sar1b. Curr Opin Lipidol. 2004, 15: 191-197. 10.1097\/00041433-200404000-00012.","journal-title":"Curr Opin Lipidol"},{"key":"187_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ng1145","volume":"34","author":"B Jones","year":"2003","unstructured":"Jones B, Jones EL, Bonney SA, Patel HN, Mensenkamp AR, Eichenbaum-Voline S, Rudling M, Myrdal U, Annesi G, Naik S, Meadows N, Quattrone A, Islam SA, Naoumova RP, Angelin B, Infante R, Levy E, Roy CC, Freemont PS, Scott J, Shoulders CC: Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet. 2003, 34: 29-31. 10.1038\/ng1145.","journal-title":"Nat Genet"},{"key":"187_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/0092-8674(94)90138-4","volume":"77","author":"C Barlowe","year":"1994","unstructured":"Barlowe C, Orci L, Yeung T, Hosobuchi M, Hamamoto S, Salama N, Rexach MF, Ravazzola M, Amherdt M, Schekman R: COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell. 1994, 77: 895-907. 10.1016\/0092-8674(94)90138-4.","journal-title":"Cell"},{"key":"187_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0092-8674(00)81577-9","volume":"93","author":"K Matsuoka","year":"1998","unstructured":"Matsuoka K, Orci L, Amherdt M, Bednarek SY, Hamamoto S, Schekman R, Yeung T: COPII-coated vesicle formation reconstituted with purified coat proteins and chemically defined liposomes. Cell. 1998, 93: 263-275. 10.1016\/S0092-8674(00)81577-9.","journal-title":"Cell"},{"key":"187_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ymgme.2007.08.120","volume":"93","author":"M Charcosset","year":"2008","unstructured":"Charcosset M, Sassolas A, Peretti N, Roy CC, Deslandres C, Sinnett D, Levy E, Lachaux A: Anderson or chylomicron retention disease: Molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein. Mol Genet Metab. 2008, 93: 74-84. 10.1016\/j.ymgme.2007.08.120.","journal-title":"Mol Genet Metab"},{"key":"187_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/35043117","volume":"1","author":"T Kirchhausen","year":"2000","unstructured":"Kirchhausen T: Three ways to make a vesicle. Nat Rev Mol Cell Biol. 2000, 1: 187-198. 10.1038\/35043117.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"187_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1242\/jcs.00215","volume":"116","author":"SA Siddiqi","year":"2003","unstructured":"Siddiqi SA, Gorelick FS, Mahan JT, Mansbach CM: COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle. J Cell Sci. 2003, 116: 415-427. 10.1242\/jcs.00215.","journal-title":"J Cell Sci"},{"key":"187_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1242\/jcs.02803","volume":"119","author":"SA Siddiqi","year":"2006","unstructured":"Siddiqi SA, Mahan J, Siddiqi S, Gorelick FS, Mansbach CM: Vesicle-associated membrane protein 7 is expressed in intestinal ER. J Cell Sci. 2006, 119: 943-950. 10.1242\/jcs.02803.","journal-title":"J Cell Sci"},{"key":"187_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1399-0004.2008.01069.x","volume":"74","author":"M Silvain","year":"2008","unstructured":"Silvain M, Bligny D, Aparicio T, Laforet P, Grodet A, Peretti N, Menard D, Djouadi F, Jardel C, Begue JM, Walker F, Schmitz J, Lachaux A, Aggerbeck LP, Samson-Bouma ME: Anderson's disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities. Clin Genet. 2008, 74: 546-552. 10.1111\/j.1399-0004.2008.01069.x.","journal-title":"Clin Genet"},{"key":"187_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/MPG.0b013e318183188f","volume":"48","author":"S Treepongkaruna","year":"2009","unstructured":"Treepongkaruna S, Chongviriyaphan N, Suthutvoravut U, Charoenpipop D, Choubtum L, Wattanasirichaigoon D: Novel missense mutations of SAR1B gene in an infant with chylomicron retention disease. J Pediatr Gastroenterol Nutr. 2009, 48: 370-373. 10.1097\/MPG.0b013e318183188f.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"187_CR17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5694\/j.1326-5377.1961.tb69860.x","volume":"48","author":"CM Anderson","year":"1961","unstructured":"Anderson CM, Townley RR, Freemanm , Johansen P: Unusual causes of steatorrhoea in infancy and childhood. Med J Aust. 1961, 48 (2): 617-622.","journal-title":"Med J Aust"},{"key":"187_CR18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1172\/JCI112590","volume":"78","author":"ME Bouma","year":"1986","unstructured":"Bouma ME, Beucler I, Aggerbeck LP, Infante R, Schmitz J: Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease. J Clin Invest. 1986, 78: 398-410. 10.1172\/JCI112590.","journal-title":"J Clin Invest"},{"key":"187_CR19","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/01.ATV.19.10.2494","volume":"19","author":"AH Dannoura","year":"1999","unstructured":"Dannoura AH, Berriot-Varoqueaux N, Amati P, Abadie V, Verthier N, Schmitz J, Wetterau JR, Samson-Bouma ME, Aggerbeck LP: Anderson's disease: exclusion of apolipoprotein and intracellular lipid transport genes. Arterioscler Thromb Vasc Biol. 1999, 19: 2494-2508.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"187_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.410140517","volume":"14","author":"S Gauthier","year":"1983","unstructured":"Gauthier S, Sniderman A: Action tremor as a manifestation of chylomicron retention disease. Ann Neurol. 1983, 14: 591-10.1002\/ana.410140517.","journal-title":"Ann Neurol"},{"key":"187_CR21","first-page":"491","volume":"46","author":"F Lacaille","year":"1989","unstructured":"Lacaille F, Bratos M, Bouma ME, Jos J, Schmitz J, Rey J: [Anderson's disease. Clinical and morphologic study of 7 cases]. Arch Fr Pediatr. 1989, 46: 491-498.","journal-title":"Arch Fr Pediatr"},{"key":"187_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2362.1995.tb01559.x","volume":"25","author":"A Nemeth","year":"1995","unstructured":"Nemeth A, Myrdal U, Veress B, Rudling M, Berglund L, Angelin B: Studies on lipoprotein metabolism in a family with jejunal chylomicron retention. Eur J Clin Invest. 1995, 25: 271-280. 10.1111\/j.1365-2362.1995.tb01559.x.","journal-title":"Eur J Clin Invest"},{"key":"187_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0021-9150(94)90115-5","volume":"108","author":"S Patel","year":"1994","unstructured":"Patel S, Pessah M, Beucler I, Navarro J, Infante R: Chylomicron retention disease: exclusion of apolipoprotein B gene defects and detection of mRNA editing in an affected family. Atherosclerosis. 1994, 108: 201-207. 10.1016\/0021-9150(94)90115-5.","journal-title":"Atherosclerosis"},{"key":"187_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1172\/JCI114996","volume":"87","author":"M Pessah","year":"1991","unstructured":"Pessah M, Benlian P, Beucler I, Loux N, Schmitz J, Junien C, Infante R: Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families. J Clin Invest. 1991, 87: 367-370. 10.1172\/JCI114996.","journal-title":"J Clin Invest"},{"key":"187_CR25","first-page":"342","volume":"17","author":"C Polonovski","year":"1970","unstructured":"Polonovski C, Navarro J, Fontaine JL, de GF, Saudubray JM, Cathelineau L: [Anderson's disease]. Ann Pediatr (Paris). 1970, 17: 342-354.","journal-title":"Ann Pediatr (Paris)"},{"key":"187_CR26","first-page":"564","volume":"30","author":"J Rey","year":"1973","unstructured":"Rey J, Jos J, Rey F, Leporrier M, Dechaux M, Ramon J, Frezal J: [Idiopathic disorder of intestinal fat transport (Anderson's disease). A further case]. Arch Fr Pediatr. 1973, 30: 564-565.","journal-title":"Arch Fr Pediatr"},{"key":"187_CR27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0016-5085(87)90133-8","volume":"92","author":"CC Roy","year":"1987","unstructured":"Roy CC, Levy E, Green PH, Sniderman A, Letarte J, Buts JP, Orquin J, Brochu P, Weber AM, Morin CL: Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B. Chylomicron retention disease. Gastroenterology. 1987, 92: 390-399.","journal-title":"Gastroenterology"},{"key":"187_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/gut.20.2.163","volume":"20","author":"BB Scott","year":"1979","unstructured":"Scott BB, Miller JP, Losowsky MS: Hypobetalipoproteinaemia--a variant of the Bassen-Kornzweig syndrome. Gut. 1979, 20: 163-168. 10.1136\/gut.20.2.163.","journal-title":"Gut"},{"key":"187_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00005176-199304000-00006","volume":"16","author":"D Strich","year":"1993","unstructured":"Strich D, Goldstein R, Phillips A, Shemer R, Goldberg Y, Razin A, Freier S: Anderson's disease: no linkage to the apo B locus. J Pediatr Gastroenterol Nutr. 1993, 16: 257-264. 10.1097\/00005176-199304000-00006.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"187_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ymgme.2009.02.003","volume":"97","author":"N Peretti","year":"2009","unstructured":"Peretti N, Roy CC, Sassolas A, Deslandres C, Drouin E, Rasquin A, Seidman E, Brochu P, Vohl MC, Labarge S, Bouvier R, Samson-Bouma ME, Charcosset M, Lachaux A, Levy E: Chylomicron retention disease: a long term study of two cohorts. Mol Genet Metab. 2009, 97: 136-142. 10.1016\/j.ymgme.2009.02.003.","journal-title":"Mol Genet Metab"},{"key":"187_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/MEG.0b013e3282ffd9f8","volume":"21","author":"D Bonnefont-Rousselot","year":"2009","unstructured":"Bonnefont-Rousselot D, Condat B, Sassolas A, Chebel S, Bittar R, Federspiel MC, Cazals-Hatem D, Bruckert E: Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B. Eur J Gastroenterol Hepatol. 2009, 21: 104-108. 10.1097\/MEG.0b013e3282ffd9f8.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"187_CR32","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s004310050882","volume":"157","author":"CP Braegger","year":"1998","unstructured":"Braegger CP, Belli DC, Mentha G, Steinmann B: Persistence of the intestinal defect in abetalipoproteinaemia after liver transplantation. Eur J Pediatr. 1998, 157: 576-578. 10.1007\/s004310050882.","journal-title":"Eur J Pediatr"},{"key":"187_CR33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0016-5085(19)32931-2","volume":"67","author":"JS Partin","year":"1974","unstructured":"Partin JS, Partin JC, Schubert WK, McAdams AJ: Liver ultrastructure in abetalipoproteinemia: Evolution of micronodular cirrhosis. Gastroenterology. 1974, 67: 107-118.","journal-title":"Gastroenterology"},{"key":"187_CR34","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1212\/WNL.43.11.2167","volume":"43","author":"HJ Kayden","year":"1993","unstructured":"Kayden HJ: The neurologic syndrome of vitamin E deficiency: a significant cause of ataxia. Neurology. 1993, 43: 2167-2169.","journal-title":"Neurology"},{"key":"187_CR35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0065-3101(24)00241-X","volume":"37","author":"RJ Sokol","year":"1990","unstructured":"Sokol RJ: Vitamin E and neurologic deficits. Adv Pediatr. 1990, 37: 119-148.","journal-title":"Adv Pediatr"},{"key":"187_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1042\/BJ20071469","volume":"413","author":"SA Siddiqi","year":"2008","unstructured":"Siddiqi SA: VLDL exits from the endoplasmic reticulum in a specialized vesicle, the VLDL transport vesicle, in rat primary hepatocytes. Biochem J. 2008, 413: 333-342. 10.1042\/BJ20071469.","journal-title":"Biochem J"},{"key":"187_CR37","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1172\/JCI1785","volume":"101","author":"J Boren","year":"1998","unstructured":"Boren J, Veniant MM, Young SG: Apo B100-containing lipoproteins are secreted by the heart. J Clin Invest. 1998, 101: 1197-1202. 10.1172\/JCI1785.","journal-title":"J Clin Invest"},{"key":"187_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/01.CIR.98.1.13","volume":"98","author":"LB Nielsen","year":"1998","unstructured":"Nielsen LB, Veniant M, Boren J, Raabe M, Wong JS, Tam C, Flynn L, Vanni-Reyes T, Gunn MD, Goldberg IJ, Hamilton RL, Young SG: Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins. Circulation. 1998, 98: 13-16.","journal-title":"Circulation"},{"key":"187_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1203\/00006450-198003000-00004","volume":"14","author":"B Christensen","year":"1980","unstructured":"Christensen B, Glueck C, Kwiterovich P, Degroot I, Chase G, Heiss G, Mowery R, Tamir I, Rifkind B: Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: the Prevalence Study of the Lipid Research Clinics Program. Pediatr Res. 1980, 14: 194-202.","journal-title":"Pediatr Res"},{"key":"187_CR40","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1146\/annurev.nutr.20.1.663","volume":"20","author":"N Berriot-Varoqueaux","year":"2000","unstructured":"Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR: The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev Nutr. 2000, 20: 663-697. 10.1146\/annurev.nutr.20.1.663.","journal-title":"Annu Rev Nutr"},{"key":"187_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.metabol.2009.07.042","volume":"59","author":"AB Cefalu","year":"2010","unstructured":"Cefalu AB, Calvo PL, Noto D, Baldi M, Valenti V, Lerro P, Tramuto F, Lezo A, Morra I, Cenacchi G, Barbera C, Averna MR: Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene. Metabolism. 2010, 59: 463-467. 10.1016\/j.metabol.2009.07.042.","journal-title":"Metabolism"},{"key":"187_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0969-8043(97)00195-4","volume":"49","author":"PM Braillon","year":"1998","unstructured":"Braillon PM, Cochat P: Analysis of dual energy X-ray absorptiometry whole body results in children, adolescents and young adults. Appl Radiat Isot. 1998, 49: 623-624. 10.1016\/S0969-8043(97)00195-4.","journal-title":"Appl Radiat Isot"},{"key":"187_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/j.semnuclmed.2007.02.007","volume":"37","author":"LA Binkovitz","year":"2007","unstructured":"Binkovitz LA, Henwood MJ, Sparke P: Pediatric dual-energy X-ray absorptiometry: technique, interpretation, and clinical applications. Semin Nucl Med. 2007, 37: 303-313. 10.1053\/j.semnuclmed.2007.02.007.","journal-title":"Semin Nucl Med"},{"key":"187_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1440-1754.2000.00534.x","volume":"36","author":"G Alex","year":"2000","unstructured":"Alex G, Oliver MR, Collins KJ: Ataxia with isolated vitamin E deficiency: a clinical, biochemical and genetic diagnosis. J Paediatr Child Health. 2000, 36: 515-516. 10.1046\/j.1440-1754.2000.00534.x.","journal-title":"J Paediatr Child Health"},{"key":"187_CR45","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1651-2227.1978.tb16264.x","volume":"67","author":"E Azizi","year":"1978","unstructured":"Azizi E, Zaidman JL, Eshchar J, Szeinberg A: Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides. Acta Paediatr Scand. 1978, 67: 796-801. 10.1111\/j.1651-2227.1978.tb16264.x.","journal-title":"Acta Paediatr Scand"},{"key":"187_CR46","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1172\/JCI110173","volume":"67","author":"MJ Malloy","year":"1981","unstructured":"Malloy MJ, Kane JP, Hardman DA, Hamilton RL, Dalal KB: Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein. J Clin Invest. 1981, 67: 1441-1450. 10.1172\/JCI110173.","journal-title":"J Clin Invest"},{"key":"187_CR47","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1212\/WNL.30.12.1286","volume":"30","author":"RG Miller","year":"1980","unstructured":"Miller RG, Davis CJ, Illingworth DR, Bradley W: The neuropathy of abetalipoproteinemia. Neurology. 1980, 30: 1286-1291.","journal-title":"Neurology"},{"key":"187_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00004836-199804000-00012","volume":"26","author":"JK Triantafillidis","year":"1998","unstructured":"Triantafillidis JK, Kottaras G, Sgourous S, Cheracakis P, Driva G, Konstantellou E, Parasi A, Choremi H, Samouilidou E: A-beta-lipoproteinemia: clinical and laboratory features, therapeutic manipulations, and follow-up study of three members of a Greek family. J Clin Gastroenterol. 1998, 26: 207-211. 10.1097\/00004836-199804000-00012.","journal-title":"J Clin Gastroenterol"},{"key":"187_CR49","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/ajcn\/27.10.1174","volume":"27","author":"TW Anderson","year":"1974","unstructured":"Anderson TW, Reid DB: A double-blind trial of vitamin E in angina pectoris. Am J Clin Nutr. 1974, 27: 1174-1178.","journal-title":"Am J Clin Nutr"},{"key":"187_CR50","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1212\/WNL.50.6.1900","volume":"50","author":"GT Vatassery","year":"1998","unstructured":"Vatassery GT, Fahn S, Kuskowski MA: Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group. Neurology. 1998, 50: 1900-1902.","journal-title":"Neurology"},{"key":"187_CR51","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10620-006-9489-2","volume":"52","author":"K Papas","year":"2007","unstructured":"Papas K, Kalbfleisch J, Mohon R: Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. Dig Dis Sci. 2007, 52: 347-352. 10.1007\/s10620-006-9489-2.","journal-title":"Dig Dis Sci"},{"key":"187_CR52","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1365-2710.2009.01027.x","volume":"34","author":"E Jacquemin","year":"2009","unstructured":"Jacquemin E, Hermeziu B, Kibleur Y, Friteau I, Mathieu D, Le CF, Moyse D, Gerardin M, Jacqz-Aigrain E, Munck A: Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis. J Clin Pharm Ther. 2009, 34: 515-522. 10.1111\/j.1365-2710.2009.01027.x.","journal-title":"J Clin Pharm Ther"},{"issue":"Suppl 1","key":"187_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/BF01800666","volume":"8","author":"DP Muller","year":"1985","unstructured":"Muller DP, Lloyd JK, Wolff OH: The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption. J Inherit Metab Dis. 1985, 8 (Suppl 1): 88-92. 10.1007\/BF01800666.","journal-title":"J Inherit Metab Dis"},{"key":"187_CR54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-2275(20)40727-8","volume":"34","author":"HJ Kayden","year":"1993","unstructured":"Kayden HJ, Traber MG: Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res. 1993, 34: 343-358.","journal-title":"J Lipid Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-5-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T20:49:55Z","timestamp":1711831795000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-5-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,29]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["187"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-5-24","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,29]]},"assertion":[{"value":"22 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}